Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Malcolm

Showing results (351-360 of 388) with videos related to

Pageof 39
Sort By:
Blood|February 5, 2005
A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survivalAzra J Alvi, Belinda Austen, Victoria J Weston, et al.
Blood|September 6, 2003
Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responsesTatjana Stankovic, Mike Hubank, Debbie Cronin, et al.
Blood|December 7, 2006
Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cellsAmanda Dutton, Ciaran B Woodman, Marilyn B Chukwuma, et al.
The Journal of Biological Chemistry|December 15, 2005
Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutationsMinKyung Yi, Xiao Tong, Angela Skelton, et al.
Blood|August 27, 2010
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivoVictoria J Weston, Ceri E Oldreive, Anna Skowronska, et al.
Disease Models & Mechanisms|September 24, 2015
T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid miceCeri E Oldreive, Anna Skowronska, Nicholas J Davies, et al.
Plos Genetics|March 19, 2016
A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour DevelopmentPhilip J Byrd, Grant S Stewart, Anna Smith, et al.
Cell Reports|June 6, 2026
Poising and connectivity of emergent human developmental enhancers in the transition from naive to primed pluripotencyMarina C Nocente, Monica Della Rosa, Andrew A Malcolm, et al.
Science Advances|March 25, 2022
Genome-wide screening identifies Polycomb repressive complex 1.3 as an essential regulator of human naïve pluripotent cell reprogrammingAmanda J Collier, Adam Bendall, Charlene Fabian, et al.
Molecular Cell|February 28, 2012
Regulation of DNA-end resection by hnRNPU-like proteins promotes DNA double-strand break signaling and repairSophie E Polo, Andrew N Blackford, J Ross Chapman, et al.
Pageof 39

Showing results (351-360 of 388) with videos related to

Sort By:
Pageof 39
Blood|February 5, 2005
A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survivalAzra J Alvi, Belinda Austen, Victoria J Weston, et al.
Blood|September 6, 2003
Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responsesTatjana Stankovic, Mike Hubank, Debbie Cronin, et al.
Blood|December 7, 2006
Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cellsAmanda Dutton, Ciaran B Woodman, Marilyn B Chukwuma, et al.
The Journal of Biological Chemistry|December 15, 2005
Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutationsMinKyung Yi, Xiao Tong, Angela Skelton, et al.
Blood|August 27, 2010
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivoVictoria J Weston, Ceri E Oldreive, Anna Skowronska, et al.
Disease Models & Mechanisms|September 24, 2015
T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid miceCeri E Oldreive, Anna Skowronska, Nicholas J Davies, et al.
Plos Genetics|March 19, 2016
A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour DevelopmentPhilip J Byrd, Grant S Stewart, Anna Smith, et al.
Cell Reports|June 6, 2026
Poising and connectivity of emergent human developmental enhancers in the transition from naive to primed pluripotencyMarina C Nocente, Monica Della Rosa, Andrew A Malcolm, et al.
Science Advances|March 25, 2022
Genome-wide screening identifies Polycomb repressive complex 1.3 as an essential regulator of human naïve pluripotent cell reprogrammingAmanda J Collier, Adam Bendall, Charlene Fabian, et al.
Molecular Cell|February 28, 2012
Regulation of DNA-end resection by hnRNPU-like proteins promotes DNA double-strand break signaling and repairSophie E Polo, Andrew N Blackford, J Ross Chapman, et al.
Pageof 39